C+P treatment reduced brain damage and improved neurological function in a mouse stroke model. In rhesus monkeys, the drugs lowered body temperature, which suppressed the metabolic rate and protected the brain from stroke-related injury.

The researchers then moved to a small Phase I clinical trial with 32 stroke patients. The treatment was safe at a 100 mg dose and successfully lowered body temperature while slowing the body’s energy use, an effect that the researchers suggest helps protect the brain after a stroke.